Target delivering paclitaxel by ferritin heavy chain nanocages for glioma treatment
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Glioma is one of the most common aggressive brain malignancies, but the treatment of glioma is still far from satisfying. The efficiency of chemotherapy - the major choice of glioma treatment - is severely limited by low chemotherapeutic agents delivery across blood-brain barrier (BBB) and low tumor retention. Therefore, a safe and effective drug delivery system to help chemotherapy agents traverse the BBB and accumulate at tumor sites is urgently needed. Paclitaxel (PTX) is one of the most common and effective chemotherapy agent, however, it suffers from extremely low solubility and BBB penetration ability. Herein, we developed endogenous human ferritin heavy chain nanocage (HFn) as PTX carrier, which could specifically bind to widely overexpressed transferrin receptor 1 (TfR1) on BBB and glioma cells. We propose that this binding may help PTX cross the BBB and enhance its tumor accumulation. PTX-loaded HFn (HFn-PTX) was prepared and exhibited satisfactory targeting effect in Bend.3 and C6 cells in vitro. In vivo tissue biodistribution assay also demonstrated that HFn-PTX could indeed promote the accumulation of PTX in the brain. HFn-PTX exhibited the best anti-tumor effect with median survival time of 30 days, significantly longer than that of free PTX (14 days) and physiological saline group (13 days). In summary, we have designed and fabricated an effective delivery system for PTX to treat glioma. We also provided evidences that Transferrin (Tf) could not prevent the binding of HFn to TfR1 nor consequent TfR1-mediated HFn uptake, providing a clue for future research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ferritins: A family of molecules for iron storage, antioxidation and more
Arosio, P., Ingrassia, R., & Cavadini, P. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.09.004 · Cited by 886
Solving the structure of human H ferritin by genetically engineering intermolecular crystal contacts
Lawson, D. M., Artymiuk, P. J., Yewdall, S. J., Smith, J. M. A., Livingstone, J. C., Treffry, A., Luzzago, A., Levi, S., Arosio, P., Cesareni, G., et al. (1991) · Nature · doi:10.1038/349541a0 · Cited by 777
Nanoparticle transport across the blood brain barrier
Grabrucker, A. M., Ruozi, B., Belletti, D., Pederzoli, F., Forni, F., Vandelli, M. A., & Tosi, G. (2016) · Tissue Barriers · doi:10.1080/21688370.2016.1153568 · Cited by 217
Pardridge, W. M. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2015.1042364 · Cited by 159
Cited by
Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Wang, B., Hu, S., Teng, Y., Chen, J., Wang, H., Xu, Y., Wang, K., Xu, J., Cheng, Y., & Gao, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01889-y · Cited by 558
Song, N., Zhang, J., Zhai, J., Hong, J., Yuan, C., & Liang, M. (2021) · Accounts of Chemical Research · doi:10.1021/acs.accounts.1c00267 · Cited by 233
The Role of Iron in Cancer Progression
Guo, Q., Li, L., Hou, S., Yuan, Z., Li, C., Zhang, W., Zheng, L., & Li, X. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.778492 · Cited by 150
Self-citationWang, L., Shi, Y., Jiang, J., Li, C., Zhang, H., Zhang, X., Jiang, T., Wang, L., Wang, Y., & Feng, L. (2022) · Small · doi:10.1002/smll.202203678 · Cited by 71
Self-citationDuan, S., Sun, F., Qiao, P., Zhu, Z., Geng, M., Gong, X., Li, Y., & Yao, H. (2023) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.2c01179 · Cited by 23
Metadata
- Authors
- Liu, W., Lin, Q., Fu, Y., Huang, S., Guo, C., Li, L., Wang, L., Zhang, Z., & Zhang, L.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2020-07
- Volume
- 323
- Pages
- 191-202
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2996165724
- Cited by
- 116
- References
- 4
- FWCI
- 2.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Target delivering paclitaxel by ferritin heavy chain nanocages for glioma treatment. https://app.cochat.ai/papers/10.1016/j.jconrel.2019.12.010
- The paper
- Liu, W., Lin, Q., Fu, Y., Huang, S., Guo, C., Li, L., Wang, L., Zhang, Z., & Zhang, L. (2020). Target delivering paclitaxel by ferritin heavy chain nanocages for glioma treatment. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2019.12.010
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.